| Recruiting | Autologous CAR-T Cell Therapy for Refractory and Relapsing Ulcerative Colitis: A Single-Center Exploratory Stu UC | EARLY_Phase 1 | 2026-02-04 |
| Not Yet Recruiting | Phase I/II Study of SENL103 for Relapsed or Refractory Multiple Myeloma: A Multicenter, Open-Label, Single-Arm Multiple Myeloma in Relapse, Multiple Myeloma Refractory | Phase 1 / Phase 2 | 2026-02-01 |
| Not Yet Recruiting | Phase II Trial of S101 Autologous Anti-CD7 CAR-T Cells in Patients With R/R T-LBL/ALL. T Lymphoblastic Leukemia/Lymphoma | Phase 2 | 2025-11-28 |
| Not Yet Recruiting | Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases Autoimmune Diseases | Phase 1 / Phase 2 | 2025-09-30 |
| Recruiting | Assessment of Senl_B19 CAR-T Cells in Relapsed/Refractory CD19+ B-ALL B-ALL | Phase 2 | 2025-01-10 |
| Unknown | the Safety and Efficacy of SENL103 Autologous T Cell Injection Multiple Myeloma | EARLY_Phase 1 | 2023-08-21 |
| Recruiting | CD7 CAR-T in Adults With Relapsed or Refractory T-LBL/ALL Clinical Study T-lymphoblastic Lymphoma, T-ALL | Phase 1 | 2023-08-15 |
| Recruiting | The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies Acute Lymphoblastic Leukemia, Lymphoma, Multiple Myeloma | N/A | 2022-09-07 |
| Recruiting | Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL T-cell Acute Lymphoblastic Leukemia/Lymphoma | N/A | 2022-08-29 |
| Unknown | SENL101 Autologous T Cell Injection in Adults With Relapsed or Refractory CD7+ Hematolymphoid Malignancies T-ALL, Lymphoma, T-Cell | Phase 1 | 2022-05-01 |
| Unknown | Universal CAR-γδT Cell Injection in the AML Patients AML | N/A | 2022-04-20 |
| Recruiting | To Observe the Dual-target Chimeric Antigen Receptor T Cells in the Treatment of B Cell Hematologic Tumors 19 and 22+ B Cell Hematologic Tumors, 19 and 20+ B Cell Hematologic Tumors | Phase 1 | 2022-04-08 |
| Unknown | The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme. Glioblastoma Multiforme, Adult | EARLY_Phase 1 | 2022-02-15 |
| Unknown | Safety and Efficacy of CD19/CD22 Dual Targeted CAR-T Cell Therapy in R/R B-Cell Acute Lymphoblastic Leukemia CD19+ and CD 22+ B-ALL | EARLY_Phase 1 | 2021-08-15 |
| Completed | Cell Therapy for CD7 Positive Acute Myeloid Leukemia or Mixed Lineage Leukemia Leukemia, T Cell | N/A | 2021-05-10 |
| Unknown | Clinical Study of SL19+22 CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma Non-hodgkin's Lymphoma | N/A | 2021-05-01 |
| Unknown | Senl-T7 CAR-T Cells for Treatment of Relapsed or Refractory CD7+ Lymphoma Lymphoma, T-Cell | N/A | 2021-01-27 |
| Unknown | Clinical Study of SenL-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ T-cell Lymphoblastic Le SenL-T7 CAR T Cells for CD7+ T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma | N/A | 2021-01-27 |
| Unknown | Clinical Study of Universal CAR-γδT Cell Injection in the Treatment of Patients With Relapsed AML After Transp AML | N/A | 2020-12-16 |
| Unknown | Senl-h19 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory Acute Lymphoblastic Leu B-ALL | N/A | 2020-12-03 |
| Unknown | Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Pl Plasma Cell Tumors | N/A | 2020-10-22 |
| Unknown | A Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Hodgkin's Lymphoma | N/A | 2020-10-22 |
| Unknown | A Multicenter Clinical Study on the Safety and Efficacy of CAR-T in the Treatment of Relapsed / Refractory Non Non-hodgkin's Lymphoma | N/A | 2020-10-22 |
| Completed | Cell Therapy for CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD7-Specifi T-cell Acute Lymphoblastic Leukemia/Lymphoma | Phase 1 | 2020-10-01 |
| Unknown | Safety and Efficacy Study of SL1904B CAR-T Cells for Relapsed or Refractory B-Cell Acute Lymphocyte Leukemia B-ALL | N/A | 2020-09-01 |
| Unknown | Safety and Efficacy Study of CD22 CAR-T Cells for Relapsed or Refractory Acute Lymphoblastic Leukemia B-ALL | N/A | 2020-09-01 |
| Unknown | Anti-PD-L1 Armored Anti-CD22 CAR-T/CAR-TILs Targeting Patients With Solid Tumors Solid Tumor, Adult, Cervical Cancer, Sarcoma | Phase 1 | 2020-08-01 |
| Unknown | Clinical Trial of SL1904B CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma Non-hodgkin's Lymphoma | N/A | 2020-06-30 |
| Unknown | Immunotherapy With BCMA CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma Multiple Myeloma | N/A | 2020-06-30 |
| Unknown | Clinical Trial of CAR-T in the Treatment of Relapsed and Refractory Hematopoietic and Lymphoid Tissue Tumors i Leukemia, Lymphoma | N/A | 2020-06-23 |
| Unknown | CAR-T Cells in the Treatment of Malignant Hematological Tumors Lymphoma, B-Cell, Leukemia, B-cell, Leukemia, T-Cell | N/A | 2020-04-27 |
| Unknown | Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation Adult B Acute Lymphoblastic Leukemia | EARLY_Phase 1 | 2020-04-01 |
| Unknown | CAR-T Cells in Treating Patients With Relapsed or Refractory NHL Refractory Indolent Adult Non-Hodgkin Lymphoma | EARLY_Phase 1 | 2020-04-01 |
| Unknown | CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma Relapsed or Refractory Multiple Myeloma | EARLY_Phase 1 | 2020-04-01 |
| Unknown | CAR-T for Children With Relapsed and Refractory Acute Lymphoblastic Leukemia Childhood Acute Lymphoblastic Leukemia | EARLY_Phase 1 | 2020-04-01 |
| Unknown | Senl_1904A and Senl_1904B Chimeric Antigen Receptor （CAR） T-Cell in the Treatment of r/ r Acute B Lymphocytic Acute Lymphocytic Leukemia | Phase 1 | 2019-01-02 |
| Unknown | Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Myelocytic Leukemia Acute Myelocytic Leukemia | Phase 1 | 2018-12-26 |
| Unknown | CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies Leukemia, Lymphoma, Multiple Myeloma of Bone (Diagnosis) | Phase 1 / Phase 2 | 2017-08-29 |
| Unknown | CAR-T Therapy in Relapsed or Refractory Haematopoietic and Lymphoid Malignancies Leukemia, Lymphoma | Phase 1 | 2016-12-26 |
| Unknown | CAR T Cells for Refractory B Cell Malignancy B-Cell Leukemia, B-Cell Lymphoma | Phase 1 / Phase 2 | 2016-06-01 |